Kim, AY, et al.
An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. Journal of Infection Disease
2013; 207: S1–6.
Shepard, CW, et al.
Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases
2005; 5: 558–567.
Xia, X, et al.
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health
2008; 122: 990–1003.
McCarthy, JJ, Flynn, N. Hepatitis C in methadone maintenance patients: prevalence and public policy implications. Journal of Addiction Disease
2001; 20: 19–31.
Zhuang, X, et al.
Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. Drug and Alcohol Dependence
2012; 126: 286–295.
Paez, Jimenez A, et al.
Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS ONE
2009; 4: e7193.
Alter, MJ, et al.
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine
1999; 341: 556–562.
Cavlek, TV, et al.
Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia. Central European Journal of Public Health
2011; 19: 26–29.
Dursun, M, et al.
Prevalence of Hepatitis C in adults in the south-eastern region of Anatolia: a community-based study. Hepatology Reseach
2004; 29: 75–80.
Zhou, YB, et al.
The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China. BMC infectious Diseases
2014; 14: 134.
Weidmann, C, et al.
A spatial regression analysis of German community characteristics associated with voluntary non-remunerated blood donor rates. Vox Sanguinis
2012; 102: 47–54.
Zhou, YB, et al.
Geographical variations in risk factors associated with HIV infection among drug users in a prefecture in Southwest China. Infectious Diseases of Poverty
2015; 4: 38.
Zhou, YB, et al.
HIV-, HCV-, and co-infections and associated risk factors among drug users in southwestern China: a township-level ecological study incorporating spatial regression. PLoS ONE
2014; 9: e93157.
Yin, W, et al.
Scaling up the national methadone maintenance treatment program in China: achievements and challenges. International Journal of Epidemiology
2010; 39: 29–37.
Du, WJ, et al.
Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug and Alcohol Dependence
2008; 94: 158–164.
Pang, L, et al.
Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS
2007; 21: S103–107.
Yang, TC, Matthews, SA. Understanding the non-stationary associations between distrust of the health care system, health conditions, and self-rated health in the elderly: a geographically weighted regression approach. Health Place
2012; 18: 576–585.
Champion, JK, et al.
Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. American Journal of Epidemiology
2004; 159: 514–519.
Thorpe, LE, et al.
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology
2002; 155: 645–653.
Hagan, H, et al.
Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health
2001; 91: 42–46.
Villano, SA, et al.
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology
1997; 35: 3274–3277.
Yen, YF, et al.
Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan. BMC Public Health
2012; 12: 1066.
Backmund, M, et al.
Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. European Journal of Epidemiology
2003; 18: 563–568.
Chen, HT, et al.
Correlations between compulsory drug abstinence treatments and HIV risk behaviors among injection drug users in a border city of South China. AIDS Education Prevention
2013; 25: 336–348.
Bao, YP, et al.
Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China. Journal of Acquired Immune Deficiency Syndromes
2012; 60: 438–446.
Kassaian, N, et al.
Hepatitis C Virus and associated risk factors among prison inmates with history of drug injection in Isfahan, Iran. International Journal of Prevention Medicine
2012; 3: S156–161.
Abdel-Aziz, F, et al.
Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology
2000; 32: 111–115.
Lelutiu-Weinberger, C, et al.
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Social Science & Medicine
2009; 68: 579–590.
Tohme, RA, Holmberg, SD. Is sexual contact a major mode of hepatitis C virus transmission?
2010; 52: 1497–1505.